Guam Senators Plan to Discuss Four Anti-Smoking Bills

Regulations by 2FIRSTS.ai
Dec.12.2023
Guam Senators Plan to Discuss Four Anti-Smoking Bills
Guam senators plan to discuss four bills in a public hearing on Tuesday to curb teenage smoking.

According to a report by Guampdn, Guam senators are planning to discuss four bills in a public hearing on Tuesday, December 12, aimed at curbing teenage smoking on the island. The hearing will take place at 1:30 PM at the Guam Legislature Building. These bills have been proposed by Senator Sabina Perez.

 

Senator Perez highlighted the detrimental effects of tobacco and nicotine use and dependence, particularly on adolescents who are still in the developmental stage. According to a report from the State Epidemiological Outcomes Workgroup, the usage of electronic nicotine delivery systems, commonly known as "e-cigarettes," is alarmingly high among Guam's teenagers. Approximately one in four high school students, or 26.5%, and approximately one in four middle school students, or 23.5%, reported current usage of e-cigarettes.

 

Senator Perez expressed that these data are shocking. She stated that some studies have found that teenagers who smoke and are exposed to nicotine are more likely to become addicted, which can harm their cognitive development. Furthermore, addiction during adolescence is also more difficult to overcome.

 

Senator Perez stated that tobacco-related diseases are currently the leading cause of death in Guam, and tobacco control policies are closely associated with reducing smoking and smokeless tobacco use. She emphasized the need for a comprehensive approach to control the spread of tobacco and nicotine products, enhance youth defense mechanisms, raise their health awareness, and promote a more active lifestyle.

 

Senator Perez mentioned that the passage of bills 186, 187, 194, and 185 will strengthen tobacco control laws, prevent youth access to tobacco and nicotine products, and allocate more resources towards education, prevention, cessation, and enforcement efforts.

 

Bill 194-37 requires any retailer selling tobacco and nicotine products to undergo training before obtaining a license.

 

The bill will increase fines and license suspensions for the sale of products without a permit. For first-time offenders, fines will be raised to $5,000. For second-time offenders, fines will be increased to $10,000 and the offender will be ineligible for a permit for two years following the fine. For third-time offenders, fines will be raised to $20,000. Additionally, according to the bill, there will be an increase in funding and enforcement for tobacco and nicotine education and prevention programs.

 

Bill No. 187-37 will prohibit the sale of tobacco or e-cigarette products in Guam through vending machines. Meanwhile, Bill No. 195-37 aims to restrict the advertising of tobacco products or e-cigarettes.

 

Indirect advertisements for various tobacco products still remain widespread in retail stores, shop windows, and parking lots. This bill aims to prohibit the advertising of tobacco products or e-cigarettes through various media such as television, radio, print, as well as within 6 feet of retail points.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
White House Pulls Heidi Overton's FDA Nomination as Vaccine, Abortion Pill and Vaping Disputes Fuel Senate Opposition
The White House withdrew Heidi Overton's nomination to lead the U.S. Food and Drug Administration (FDA) on November 17, 2026, a day before a scheduled Senate committee vote. Overton faced questions from Republican and Democratic senators over vaccines, abortion medication and flavored nicotine products. In May, the FDA granted its first marketing authorizations for non-tobacco, non-menthol e-cigarette flavors, including mango and blueberry pods from Glas. Republican Senator Susan Collins challenged recent authorizations for flavored vaping and nicotine pouch products during Overton's September confirmation hearing. The FDA remains under Acting Commissioner Kyle Diamantas.
FDA
Nov.18
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
On-Site Report | After FDA Announces Review of PMTA Framework, CTP Director Details Reform Priorities
FDA CTP Director Bret Koplow used his FDLI keynote in Washington to outline how the agency is rethinking the PMTA framework. He discussed category-specific review, nicotine pouch and sPMTA pilots, AI-assisted review, a 70% reduction in pending applications, and a major staffing constraint: CTP currently has only nine scientific review teams. He also reaffirmed tobacco harm reduction while stressing youth protection, flavored products, risk communication, and the challenge of unauthorized e-cigarettes.
Regulations
Oct.06
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23